Image source: © 2025 Krish Capital Pty. Ltd.

Highlights

  • The Share Purchase Plan (SPP) attracted applications totaling about AUD 8.7 million.
  • 2,438,872 new shares to be issued at AUD 2.05 each after pro-rata scale back.
  • Excess application funds will be refunded in line with SPP rules.

Artrya Limited (ASX:AYA) has announced the completion of its Share Purchase Plan (SPP), which opened on 15 September 2025 and closed early on 26 September 2025, receiving total applications of around AUD 8.7 million.

The company targeted AUD 5 million in funds and applied a pro-rata scale back to reduce applications to this level. Following this adjustment, 2,438,872 new fully paid ordinary shares will be issued, raising roughly AUD 5 million before costs.

Eligible shareholders were offered the option to subscribe at AUD 2.05 per share, the same price as the AUD 75 million placement announced on 9 September 2025.

About Artrya

Artrya Limited is an Australian medtech firm developing AI-based tools for detecting and managing coronary artery disease.

AYA shares were trading at AUD 2.4 per share at the time of writing on 3 October 205.